Search Within

Lee M Krug

Formats
  1. Journal Article (92)
  2. Meeting Abstract (77)
  3. Book Section (8)
  4. Book Whole (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (126)
  3. Thoracic Oncology (122)
  4. Surgery (49)
  5. Department of Pathology and Laboratory Medicine (47)
  6. Nursing (37)

More Groups

People
  1. Mark Kris (86)
  2. Vincent Miller (43)
  3. Valerie Rusch (41)
  4. Christopher Azzoli (37)
  5. Maria Pietanza (37)
  6. Marjorie Zauderer (34)

More People

Years
  1. 2018 (1)
  2. 2017 (2)
  3. 2016 (8)
  4. 2015 (14)
  5. 2014 (18)
  6. 2013 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (43)
  2. Journal of Clinical Oncology (42)
  3. Clinical Cancer Research (14)
  4. Lung Cancer (11)
  5. Journal of the National Comprehensive Cancer Network (10)
  6. Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (63)
  2. American Society of Clinical Oncology (42)
  3. American Association for Cancer Research (19)
  4. Elsevier Ireland Ltd. (10)
  5. Harborside Press (10)
  6. Springer (9)

More Publishers

Results (178)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer
    Journal Article

    Miller, V. A.; Krug, L. M.; Ng, K. K.; Pizzo, B.; Perez, W.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate
    Journal Article

    Krug, L. M.; Ng, K. K.; Kris, M. G.; Miller, V. A.; Tong, W.; Heelan, R. T.; Leon, L.; Leung, D.; Kelly, J.; Sirotnak, F. M.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma
    Journal Article

    Miller, V. A.; Ng, K. K.; Krug, L. M.; Perez, W.; Pizzo, B.; Heelan, R. T.; Kris, M. G.
    Cancer (2000)

    Fulltext@MSK | Save
  • Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer
    Journal Article

    Krug, L. M.; Miller, V. A.; Kalemkerian, G. P.; Kraut, M. J.; Ng, K. K.; Heelan, R. T.; Pizzo, B. A.; Perez, W.; McClean, N.; Kris, M. G.
    Annals of Oncology (2000)

    Fulltext@MSK | Save
  • Phase II trial of docetaxel and vinorelbine in advanced non-small cell lung cancer (NSCLS) with analysis of bcl-2 and bax expression
    Meeting Abstract

    Krug, L. M.; Filippa, D. A.; Kris, M. G.; Zelenetz, A.; Heelan, R. T.; Grant, S. C.; Ng, K. K.; Pizzo, B. A.; Miller, V. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin (PDX), a new antifolate
    Meeting Abstract

    Krug, L. M.; Ng, K. K.; Miller, V. A.; Heelan, R. T.; Tong, W.; Kelly, J.; Sirotnak, F. M.; Kris, M. G.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer
    Journal Article

    Krug, L. M.; Miller, V. A.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save
  • Strategies to eradicate minimal residual disease in small cell lung cancer: High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination
    Journal Article

    Krug, L. M.; Grant, S. C.; Miller, V. A.; Ng, K. K.; Kris, M. G.
    Seminars in Oncology (1999)

    Fulltext@MSK | Save